Concepedia

Publication | Closed Access

MATILDE chemotherapy regimen for primary CNS lymphoma

DOI

43

Citations

9

References

2014

Year

Andrés J.M. Ferreri, Fabio Ciceri, Alba A. Brandes, Mauro Montanari, Monica Balzarotti, Michele Spina, Fiorella Ilariucci, Francesco Zaja, Caterina Stelitano, Flavio Bobbio,
Neurology

Abstract

This study provides Class IV evidence that in patients with PCNSL, MATILDE chemotherapy followed by response-tailored radiotherapy increases the probability of disease remission at 12 years.

References

YearCitations

Page 1